Ibrutinib efficacy and tolerability in patients with relapsed chronic lymphocytic leukemia following allogeneic HCT
Ryan, C. E., Sahaf, B., Logan, A. C., OBrien, S., Byrd, J. C., Hillmen, P., Brown, J. R., Dyer, M. J. S., Mato, A. R., Keating, M. J., Jaglowski, S., Clow, F., Rezvani, A. R., Styles, L., Coutre, S. EVolume:
128
Language:
english
Journal:
Blood
DOI:
10.1182/blood-2016-06-715284
Date:
December, 2016
File:
PDF, 2.15 MB
english, 2016